Status:
COMPLETED
Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI
Lead Sponsor:
IVI Madrid
Conditions:
Infertility
Eligibility:
FEMALE
18-40 years
Brief Summary
Premature luteinization in patients undergoing IUI can occur in up to 24% of cycles. These patients, according to recent data, have a lower pregnancy rate than controls. The possibility to avoid prema...
Detailed Description
The purpose of this study was to investigate whether a subset of patients benefits from GnRHa administration during IUI. PL was tested for in patients who were undergoing artificial insemination proce...
Eligibility Criteria
Inclusion
- previous failed IUI cycle with premature luteinization
Exclusion
- 39 years or older
- not eligible for IUI (patent tubes, \> 3 million capacitated spermatozoa)
- 4 previous IUI cycles
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
662 Patients enrolled
Trial Details
Trial ID
NCT00780858
Start Date
October 1 2008
End Date
March 1 2011
Last Update
May 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI-Madrid
Madrid, Spain, 28023